A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.
A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.
复制标题
DOI:
10.1213/ane.0000000000001413
复制
发表时间:
2016-12
影响因子:
5.7
通讯作者:
Viola F
中科院分区:
文献类型:
--
作者:
Ferrante EA;Blasier KR;Givens TB;Lloyd CA;Fischer TJ;Viola F
Major surgical procedures often result in significant intra and postoperative bleeding. The ability to identify the cause of the bleeding has the potential to reduce the transfusion of blood products and improve patient care. We present a novel device, the Quantra™ Hemostasis Analyzer, which has been designed for automated, rapid, near patient monitoring of hemostasis. The Quantra is based on SEER Sonorheometry, a proprietary technology that uses ultrasound to measure clot time and clot stiffness from changes in viscoelastic properties of whole blood during coagulation. We present results of internal validation and analytical performance testing of the technology and demonstrate the ability to characterize the key functional components of hemostasis.